Primary prevention using losartan in type 1 diabetic patients significantly reduces retinopathy.
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000517:prevention & control*; D018450:Disease Progression; D004656:Enalapril / Q000627:therapeutic use; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D011322:Primary Prevention
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D019808:Losartan